Other OTC - Delayed Quote USD

Novozymes A/S (NVZMY)

55.66 -0.09 (-0.16%)
At close: April 24 at 3:48 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Ester Baiget President & CEO 2.77M -- 1971
Mr. Rainer Lehmann Executive VP & CFO 746.07k -- 1975
Mr. Anders Lund Chief Operating Officer 903.89k -- 1973
Mr. Claus Crone Fuglsang Chief Scientific Officer -- -- 1968
Mr. Tobias Cornelius Bjorklund Head of Investor Relations -- -- --
Ms. Winnie Hoejvang Bugel General Counsel of Legal -- -- 1965
Mr. Tue Micheelsen Vice President of Global Sales & Marketing -- -- --
Mr. Morten Enggaard Rasmussen Executive Vice President of People & Stakeholder Relations -- -- 1976
Ms. Tina Sejersgaard Fano Executive Vice President of Planetary Health Biosolutions 889.54k -- 1969
Ms. Amy Byrick Executive Vice President of Human Health Biosolutions -- -- 1974

Novozymes A/S

Krogshoejvej 36
Bagsvaerd, 2880
Denmark
45 44 46 00 00 https://www.novozymes.com
Full Time Employees: 
6,397

Description

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

Corporate Governance

Novozymes A/S’s ISS Governance QualityScore as of April 1, 2024 is 2. The pillar scores are Audit: 9; Board: 2; Shareholder Rights: 9; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers